Display options
Share it on

F1000 Med Rep. 2009 Oct 29;1. doi: 10.3410/M1-81.

Advances in the management of asymptomatic hyperparathyroidism.

F1000 medicine reports

Maria Luisa Brandi

Affiliations

  1. Bone and Mineral Metabolism Unit, Department of Internal Medicine, University of Florence and AOUC Viale Pieraccini 6, 50138 Florence Italy.

PMID: 20948697 PMCID: PMC2948336 DOI: 10.3410/M1-81

Abstract

Asymptomatic primary hyperparathyroidism (PHPT), a condition defined as hyperparathyroidism that lacks specific symptoms or signs and with calcium levels of less than 1 mg/dL above the upper limit of normal, is a common clinical problem. Two previous conferences on the management of asymptomatic PHPT (a Consensus Development Conference and a National Institutes of Health workshop) indicated that medical monitoring rather than surgery is appropriate in certain patients with this condition. The Third International Workshop on the management of PHPT reviewed evidence that has become available since the last workshop in 2002. The purpose of this report is to describe recent advances reviewed during the third workshop on asymptomatic PHPT held in 2008.

References

  1. J Clin Endocrinol Metab. 2009 Feb;94(2):335-9 - PubMed
  2. J Bone Miner Res. 2002 Nov;17 Suppl 2:N1-162 - PubMed
  3. J Bone Miner Res. 1991 Oct;6 Suppl 2:S1-166 - PubMed
  4. J Clin Endocrinol Metab. 2009 Feb;94(2):373-81 - PubMed
  5. J Bone Miner Res. 1991 Oct;6 Suppl 2:S85-9; discussion S121-4 - PubMed
  6. J Clin Endocrinol Metab. 2009 Feb;94(2):351-65 - PubMed
  7. J Clin Endocrinol Metab. 2009 Feb;94(2):340-50 - PubMed
  8. J Clin Endocrinol Metab. 2009 Feb;94(2):366-72 - PubMed

Publication Types